About type 1 diabetes research
JDRF exists for the millions of children, adults and families challenged by type 1 diabetes (T1D) every single day. Their determination to overcome this chronic, life-threatening disease strengthens ours to end it.
T1D is an autoimmune disease in which a person's pancreas loses the ability to produce insulin—a hormone essential to turning food into energy. It strikes both children and adults suddenly and is unrelated to diet and lifestyle. It requires constant carbohydrate counting, blood-glucose testing and lifelong dependence on injected or infused insulin.
We’ve raised $12.4 million for type 1 diabetes research since the first JDRF Ride event in 2004. Here are just a couple of T1D research advancements from the past 14 years to help illustrate what this impact looks like:
- In 2005, one year after our first Ride, the first-ever human clinical trial of encapsulated islets took place. Today, four major global pharmaceutical companies have substantial and different encapsulation methods currently under trial in patients, with a view to becoming commercially available.
- In 2006, JDRF established the Artificial Pancreas Consortium with a mission to accelerate the development of systems for automated control of blood glucose. Just ten years later, the first “closed-loop” artificial pancreas system was FDA-approved in 2016 for use in the USA.
JDRF is the largest non-government funder of T1D research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. But we can't do it without you. Around 40 Australian research projects are supported by JDRF today, but there are dozens more that need our help.
Together, we will achieve something great in cycling and medical research.
JDRF exists for the millions of children, adults, and families affected by T1D every day. Their determination to overcome this disease inspires us and strengthens our resolve to create a world without T1D.
JDRF is the T1D research organisation with the plan, influence and ability to not just deliver hope, but a series of life-changing therapies that will progressively remove the burden of T1D.
JDRF combines aggressive fundraising and hands-on collaboration with a broad range of scientific, regulatory, and corporate partners, toward improving the lives of those living with T1D and, ultimately, finding a cure.